FDA Okays Upadacitinib for Giant Cell Arteritis ...Middle East

Medscape - News
FDA Okays Upadacitinib for Giant Cell Arteritis
This is the first and only oral JAK inhibitor indicated for giant cell arteritis, according to the manufacturer AbbVie. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Okays Upadacitinib for Giant Cell Arteritis )

Also on site :



Latest News